Views are my own.
Is there a typo in the first figure? I think the answer to the MMLU (top) question should be B, not A, because the greatest common factor of 36 and 90 is 18, not 9. (Not of course the central point of your paper/post, but it tripped me up when reading.)
Thanks for this!
If trying to avoid diminishing marginal returns within a cause area was the only reason for donation splitting, then I think pooling donations in a managed fund could be a more effective way of coordinating. Fund managers can specialize in researching where the highest-marginal-value funding gaps are.
But thereâs also a funging argument that, given the existence of large funds that are trying to do this, it matters less exactly which high-impact charities smaller donors choose. For example, if smaller donations were suboptimally allocated across GiveWellâs top charities, the GiveWell Top Charities Fund would attempt to balance things out.
Iâm also confused about this.
As I understand things there are now two different global health funds under the Effective Ventures umbrella, both of which currently amount to deferring to GiveWell (which, to be clear, I think makes a lot of sense!) with extra steps.
First thereâs the EA Funds Global Health and Development Fund, which really seems to be equivalent to the GiveWell All Grants fund but with EA Funds branding. The fund managers are listed as Elie Hassenfeld (co-founder and CEO of GiveWell) and GiveWell Staff, and the GiveWell UK FAQ says:
GiveWell acts as the manager of the Fund and directs EA Funds on where to grant it. Giving to the GH&D Fund is analogous to giving to GiveWell's All Grants Fund in that we may allocate the Fund to less certain but still high-expected-value opportunities outside of our top charities. You might choose to give to the GH&D Fund instead of our All Grants Fund via GiveWell UK if you would also like to support other cause areas through EA Funds (such as its Animal Welfare Fund, Long-Term Future Fund, or EA Infrastructure Fund).
That last sentence is the only publicly stated justification Iâve found for why the EA Funds GH&D Fund exists. It doesnât seem very compelling to me. I guess it would have been awkward to create EA Funds for the other cause areas but not for global health?
And now thereâs the GWWC Global Health and Wellbeing Fund, whose webpage says:
[Grants from the fund] may include allocations to:
- Charities or projects recommended by an evaluator/grantmaker the research team has evaluated (such as a grant to Against Malaria Foundation, which is recommended by GiveWell).
- A fund run by an evaluator the research team has evaluated (such as a grant to whichever GiveWell funds can best use it).
- Charities or projects the research team has reason to believe are highly impactful, including cases where this reasoning isnât the result of deferring to a vetted evaluator (though we expect this to be rare, as the research team generally evaluates evaluators rather than individual charities or projects).
âŚ
For this first round, we expect to allocate donations to this fund in consultation with GiveWell, based on our recent evaluation of its work. In practice, this will likely closely resemble the grantmaking of GiveWellâs All Grants Fund⌠Our research team may identify new funding opportunities (outside of those recommended by GiveWell) in future grantmaking rounds.
Here thereâs potential at least for future divergence from GiveWellâs recommendations. But it seems this will really only come into its own if GWWC finds another global health evaluator it endorses, or develops substantial global health expertise of its own.
More broadly, now that GWWC has launched its own funds, how does Effective Ventures expect the relationship between GWWC and other grantmakers under the EV fiscal sponsorship umbrella to evolve? What would the internal governance and external communications look like if, hypothetically, the GWWC research team concluded that one of the other EV-sponsored grantmakers was allocating funds poorly?
This sounds very worthwhile â Iâm glad youâre working on this!
We will initially establish a proof of concept in one region, working closely with the government TB program.
It wasnât clear to me from the post whether youâre planning to do an impact evaluation of an existing government TB programme, or to trial a new kind of screening and preventive treatment programme in partnership with a government (which wouldnât otherwise do it without you).
We will then aim to scale nationally, with funding from the Global Fund, and expand to other countries.
Have I understood correctly that the Global Fund wouldnât be willing to fund the proof-of-concept and pilot programmes itself?
What is the likely counterfactual for the matching funds? Is this part of a wider matching campaign by Founders Pledge donors? How does it stack up against the usual concerns about matching campaigns? (See for example here.)
The switch from âGWWC pledgeâ to â10% pledgeâ makes a lot of sense to me. Iâm less sure about the coloured diamond logos. Is there any particular reason for choosing orange? Have you considered the potential for confusion with the Liberal Democrats in the UK?